{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:21:40Z","timestamp":1783459300409,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202501ZYTS151"],"award-info":[{"award-number":["YDZJ202501ZYTS151"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010211","name":"Education Department of Jilin Province","doi-asserted-by":"publisher","award":["JJKH20250633KJ"],"award-info":[{"award-number":["JJKH20250633KJ"]}],"id":[{"id":"10.13039\/501100010211","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.diabres.2026.113348","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:26:54Z","timestamp":1780154814000},"page":"113348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A comprehensive review on the latest progressions of cell-free DNA in diabetes and related microvascular or macrovascular complications"],"prefix":"10.1016","volume":"238","author":[{"given":"Jiajing","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0126-9297","authenticated-orcid":false,"given":"Dongyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.diabres.2026.113348_b0005","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s11427-024-3036-4","article-title":"Global risk factors, epidemiology, and disease burden of type 2 diabetes","volume":"69","author":"Chen","year":"2026","journal-title":"Sci China Life Sci"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13148-025-01886-0","article-title":"Unveiling the impact of DNA-methylation age acceleration on mortality risk in diabetes and pre-diabetes: insights from the US NHANES program","volume":"17","author":"Wu","year":"2025","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.diabres.2026.113348_b0015","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee for D: 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. Diabetes Care 2026, 49(Supplement_1):S27-S49.","DOI":"10.2337\/dc26-S002"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.diabres.2026.113348_b0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.diabres.2026.113348_b0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1210\/endrev\/bnad030","article-title":"Protective factors and the pathogenesis of complications in diabetes","volume":"45","author":"Yu","year":"2024","journal-title":"Endocr Rev"},{"issue":"10365","key":"10.1016\/j.diabres.2026.113348_b0035","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","article-title":"Type 2 diabetes","volume":"400","author":"Ahmad","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.diabres.2026.113348_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021503","article-title":"Cell-free DNA fragmentomics: the novel promising biomarker","volume":"24","author":"Qi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.diabres.2026.113348_b0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41591-023-02774-x","article-title":"Prospective prenatal cell-free DNA screening for genetic conditions of heterogenous etiologies","volume":"30","author":"Zhang","year":"2024","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.diabres.2026.113348_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100926","article-title":"The comings and goings of cell-free DNA: biological and clinical implications","volume":"7","author":"Malki","year":"2026","journal-title":"Med"},{"issue":"12","key":"10.1016\/j.diabres.2026.113348_b0055","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.ccell.2022.10.022","article-title":"Evaluation of cell-free DNA approaches for multi-cancer early detection","volume":"40","author":"Jamshidi","year":"2022","journal-title":"Cancer Cell"},{"issue":"10409","key":"10.1016\/j.diabres.2026.113348_b0060","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0140-6736(23)01700-2","article-title":"Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study","volume":"402","author":"Schrag","year":"2023","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.diabres.2026.113348_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146564","article-title":"Circulating bacterial DNA as a novel blood-based biomarker in type 2 diabetes mellitus (DM2): results from the PROMOTERA study","volume":"26","author":"Giacconi","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113348_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.910907","article-title":"5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney disease","volume":"13","author":"Chu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.diabres.2026.113348_b0075","article-title":"Longitudinal integrative cell-free DNA analysis in gestational diabetes mellitus","volume":"5","author":"Tang","year":"2024","journal-title":"Cell Rep Med"},{"issue":"9","key":"10.1016\/j.diabres.2026.113348_b0080","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/jdi.70071","article-title":"Circulating cell-free mitochondrial DNA in diabetes mellitus: current insights and unexplored frontiers","volume":"16","author":"Akbari","year":"2025","journal-title":"J Diabetes Investig"},{"issue":"9","key":"10.1016\/j.diabres.2026.113348_b0085","article-title":"Circulating cell-free DNA as an epigenetic biomarker for early diabetic retinopathy: a narrative review","volume":"15","author":"Li","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.diabres.2026.113348_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.120104","article-title":"The potential of circulating free DNA of methylated IGFBP as a biomarker for type 2 diabetes Mellitus: a Comprehensive review","volume":"567","author":"Belinda","year":"2025","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.diabres.2026.113348_b0095","first-page":"111","article-title":"Diagnostic potential of cell-free fetal nucleic acids in predicting pregnancy complications: a systematic review and meta-analysis on trisomy, pre-eclampsia, and gestational diabetes","volume":"23","author":"Keshari","year":"2025","journal-title":"Int J Reprod Biomed"},{"issue":"8","key":"10.1016\/j.diabres.2026.113348_b0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041595","article-title":"Innate immunity in type 1 diabetes","volume":"15","author":"Bertrand","year":"2025","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.diabres.2026.113348_b0105","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 diabetes mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.diabres.2026.113348_b0110","doi-asserted-by":"crossref","unstructured":"Ogle GD, Wang F, Haynes A, Gregory GA, King TW, Deng K, Dabelea D, James S, Jenkins AJ, Li X et al: Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0. Diabetes Res Clin Pract 2025, 225:112277.","DOI":"10.1016\/j.diabres.2025.112277"},{"issue":"11","key":"10.1016\/j.diabres.2026.113348_b0115","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.2337\/db15-0430","article-title":"Elevations in circulating methylated and unmethylated preproinsulin DNA in new-onset type 1 diabetes","volume":"64","author":"Fisher","year":"2015","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/dom.13489","article-title":"Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes","volume":"21","author":"Neyman","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"13","key":"10.1016\/j.diabres.2026.113348_b0125","doi-asserted-by":"crossref","first-page":"E1826","DOI":"10.1073\/pnas.1519286113","article-title":"Identification of tissue-specific cell death using methylation patterns of circulating DNA","volume":"113","author":"Lehmann-Werman","year":"2016","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13148-020-00906-5","article-title":"Circulating unmethylated CHTOP and INS DNA fragments provide evidence of possible islet cell death in youth with obesity and diabetes","volume":"12","author":"Syed","year":"2020","journal-title":"Clin Epigenetics"},{"issue":"6865","key":"10.1016\/j.diabres.2026.113348_b0135","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/414792a","article-title":"Beta-Cell death during progression to diabetes","volume":"414","author":"Mathis","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2026.113348_b0140","article-title":"Measurement of differentially methylated INS DNA species in human serum samples as a biomarker of islet beta cell death","volume":"118","author":"Tersey","year":"2016","journal-title":"J Vis Exp"},{"issue":"3","key":"10.1016\/j.diabres.2026.113348_b0145","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/clinem\/dgaa008","article-title":"Circulating unmethylated insulin DNA as a biomarker of human beta cell death: a multi-laboratory assay comparison","volume":"105","author":"Speake","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113348_b0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13148-017-0343-5","article-title":"Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 Diabetes: a review and future prospect","volume":"9","author":"Zhang","year":"2017","journal-title":"Clin Epigenetics"},{"issue":"4","key":"10.1016\/j.diabres.2026.113348_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094591","article-title":"Tissue-specific methylation of human insulin gene and PCR assay for monitoring beta cell death","volume":"9","author":"Husseiny","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.diabres.2026.113348_b0160","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI78142","article-title":"beta cell death and dysfunction during type 1 diabetes development in at-risk individuals","volume":"125","author":"Herold","year":"2015","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0165","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1038\/s41467-018-07466-6","article-title":"Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease","volume":"9","author":"Moss","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.diabres.2026.113348_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152662","article-title":"Circulating differentially methylated amylin DNA as a biomarker of beta-cell loss in type 1 diabetes","volume":"11","author":"Olsen","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.diabres.2026.113348_b0175","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40279-014-0296-1","article-title":"Neutrophil extracellular traps: a walk on the wild side of exercise immunology","volume":"45","author":"Beiter","year":"2015","journal-title":"Sports Med"},{"issue":"2","key":"10.1016\/j.diabres.2026.113348_b0180","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1249\/MSS.0b013e31826df4a1","article-title":"Acute severe exercise facilitates neutrophil extracellular trap formation in sedentary but not active subjects","volume":"45","author":"Syu","year":"2013","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0185","doi-asserted-by":"crossref","first-page":"15970","DOI":"10.1038\/s41598-019-52409-w","article-title":"Decreased integrity of exercise-induced plasma cell free nuclear DNA - negative association with the increased oxidants production by circulating phagocytes","volume":"9","author":"Stawski","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0190","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1038\/s41598-021-84201-0","article-title":"Circulating cell free DNA response to exhaustive exercise in average trained men with type I diabetes mellitus","volume":"11","author":"Walczak","year":"2021","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.diabres.2026.113348_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13195859","article-title":"Response of circulating free cellular DNA to repeated exercise in men with type 1 diabetes mellitus","volume":"13","author":"Walczak","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabres.2026.113348_b0200","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3389\/fphys.2019.01557","article-title":"Mitochondrial DNA promotes NLRP3 inflammasome activation and contributes to endothelial dysfunction and inflammation in type 1 diabetes","volume":"10","author":"Pereira","year":"2019","journal-title":"Front Physiol"},{"issue":"3","key":"10.1016\/j.diabres.2026.113348_b0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11892-008-0030-1","article-title":"Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus","volume":"8","author":"Abdul-Ghani","year":"2008","journal-title":"Curr Diab Rep"},{"issue":"3","key":"10.1016\/j.diabres.2026.113348_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031504","article-title":"Mitochondrial dysfunction, oxidative stress, and inter-organ miscommunications in T2D progression","volume":"25","author":"Veluthakal","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.diabres.2026.113348_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/cells8040328","article-title":"Circulating cell-free mtDNA contributes to AIM2 inflammasome-mediated chronic inflammation in patients with type 2 diabetes","volume":"8","author":"Bae","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12933-025-02656-1","article-title":"Circulating mitochondrial DNA signature in cardiometabolic patients","volume":"24","author":"Mengozzi","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"10.1016\/j.diabres.2026.113348_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222278","article-title":"Plasma mitochondrial DNA is elevated in obese type 2 diabetes mellitus patients and correlates positively with insulin resistance","volume":"14","author":"Yuzefovych","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.diabres.2026.113348_b0230","first-page":"142","article-title":"Increased levels of AIM2 and circulating mitochondrial DNA in type 2 diabetes","volume":"15","author":"Catano Canizales","year":"2018","journal-title":"Iran J Immunol"},{"issue":"8","key":"10.1016\/j.diabres.2026.113348_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084199","article-title":"Mitochondrial fraction of circulating cell-free DNA as an indicator of human pathology","volume":"25","author":"Panagopoulou","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113348_b0240","article-title":"Imeglimin-based therapies improve glycemic control and reduce mitochondrial stress in type 2 diabetes: a prospective cohort study","volume":"16","author":"Satheesan","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.diabres.2026.113348_b0245","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/jcp.53.6.466","article-title":"Presence of mitochondrial tRNA(Leu(UUR)) a to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus","volume":"53","author":"Zhong","year":"2000","journal-title":"J Clin Pathol"},{"issue":"10","key":"10.1016\/j.diabres.2026.113348_b0250","doi-asserted-by":"crossref","first-page":"e1437","DOI":"10.1002\/ctm2.1437","article-title":"Plasma extrachromosomal circular DNA is a pathophysiological hallmark of short-term intensive insulin therapy for type 2 diabetes","volume":"13","author":"Xu","year":"2023","journal-title":"Clin Transl Med"},{"issue":"11","key":"10.1016\/j.diabres.2026.113348_b0255","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1373\/clinchem.2019.305508","article-title":"5-Hydroxymethylcytosines in circulating cell-free DNA reveal vascular complications of type 2 diabetes","volume":"65","author":"Yang","year":"2019","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.diabres.2026.113348_b0260","article-title":"Quantification of circulating cell-free DNA as a NETosis marker in trauma patients with type 2 diabetes mellitus","volume":"8","author":"Sahin","year":"2025","journal-title":"Methods Protoc"},{"issue":"5","key":"10.1016\/j.diabres.2026.113348_b0265","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000444881","article-title":"Circulating neutrophil extracellular trap levels in well-controlled type 2 diabetes and pathway involved in their formation induced by high-dose glucose","volume":"83","author":"Miyoshi","year":"2016","journal-title":"Pathobiology"},{"key":"10.1016\/j.diabres.2026.113348_b0270","doi-asserted-by":"crossref","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","article-title":"Diabetic retinopathy","volume":"2","author":"Wong","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"1 Pt 1","key":"10.1016\/j.diabres.2026.113348_b0275","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ygeno.2020.11.014","article-title":"Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes","volume":"113","author":"Han","year":"2021","journal-title":"Genomics"},{"issue":"9","key":"10.1016\/j.diabres.2026.113348_b0280","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1055\/s-0042-101792","article-title":"Evaluation of circulating markers of neutrophil extracellular trap (NET) formation as risk factors for diabetic retinopathy in a case-control association study","volume":"124","author":"Park","year":"2016","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2026.113348_b0285","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/15257771003708298","article-title":"Assessment of cell-free DNA with microvascular complication of type II diabetes mellitus, using PCR and ELISA","volume":"29","author":"El Tarhouny","year":"2010","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"3","key":"10.1016\/j.diabres.2026.113348_b0290","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.diabres.2015.10.006","article-title":"Altered circulating mitochondrial DNA and increased inflammation in patients with diabetic retinopathy","volume":"110","author":"Malik","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.diabres.2026.113348_b0295","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/labmed\/lmaf034","article-title":"Specific changes in the levels of circulating cell-free mitochondrial DNA in the serum of patients with diabetic microangiopathy","volume":"56","author":"Dong","year":"2025","journal-title":"Lab Med"},{"issue":"9","key":"10.1016\/j.diabres.2026.113348_b0300","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrneph.2014.116","article-title":"Diabetic nephropathy\u2013emerging epigenetic mechanisms","volume":"10","author":"Kato","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.diabres.2026.113348_b0305","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.niox.2025.10.001","article-title":"Diabetic nephropathy: Role of nitric oxide","volume":"159","author":"Jeddi","year":"2025","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0310","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-001078","article-title":"Serum cell-free DNA and progression of diabetic kidney disease: a prospective study","volume":"8","author":"Li","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabres.2026.113348_b0315","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1164822","article-title":"The fragmentomic property of plasma cell-free DNA enables the non-invasive detection of diabetic nephropathy in patients with diabetes mellitus","volume":"14","author":"Yu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.diabres.2026.113348_b0320","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2337\/db15-0863","article-title":"NETosis delays diabetic wound healing in mice and humans","volume":"65","author":"Fadini","year":"2016","journal-title":"Diabetes"},{"issue":"3\u20134","key":"10.1016\/j.diabres.2026.113348_b0325","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000356094","article-title":"Methylation status of immune response genes promoters in cell-free DNA differs in hemodialyzed patients with diabetic nephropathy according to the intensity of anemia therapy","volume":"36","author":"Korabecna","year":"2013","journal-title":"Blood Purif"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0330","first-page":"49","article-title":"Genome-wide analysis reflects novel 5-hydroxymethylcytosines implicated in diabetic nephropathy and the biomarker potential","volume":"3","author":"Yang","year":"2022","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"issue":"12","key":"10.1016\/j.diabres.2026.113348_b0335","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/nep.14408","article-title":"Identification of circulating microbial DNA and its association with kidney function in patients with diabetic kidney disease","volume":"29","author":"Linh","year":"2024","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"10.1016\/j.diabres.2026.113348_b0340","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000522013","article-title":"Effects of L-carnitine treatment on kidney mitochondria and macrophages in mice with diabetic nephropathy","volume":"47","author":"Ito","year":"2022","journal-title":"Kidney Blood Press Res"},{"issue":"9","key":"10.1016\/j.diabres.2026.113348_b0345","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S2213-8587(20)30161-3","article-title":"Diabetes in Pregnancy Working G, Maternal Medicine Clinical Study G, Royal College of O, Gynaecologists UK: Gestational diabetes: opportunities for improving maternal and child health","volume":"8","author":"Saravanan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.diabres.2026.113348_b0350","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/jog.14268","article-title":"Update on noninvasive prenatal testing: a review based on current worldwide research","volume":"46","author":"Samura","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0355","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-016-0175-z","article-title":"beta-Cell death is decreased in women with gestational diabetes mellitus","volume":"8","author":"Kenna","year":"2016","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.diabres.2026.113348_b0360","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3264184","article-title":"Postpartum circulating cell-free insulin DNA levels are higher in women with previous gestational diabetes mellitus who develop type 2 diabetes in later life","volume":"2019","author":"Lappas","year":"2019","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0365","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13098-023-01096-9","article-title":"Higher beta cell death in pregnant women, measured by DNA methylation patterns of cell-free DNA, compared to new-onset type 1 and type 2 diabetes subjects: a cross-sectional study","volume":"15","author":"Linares-Pineda","year":"2023","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"10.1016\/j.diabres.2026.113348_b0370","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1080\/15592294.2020.1816774","article-title":"Cell-free DNA methylation and transcriptomic signature prediction of pregnancies with adverse outcomes","volume":"16","author":"Del Vecchio","year":"2021","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0375","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad492","article-title":"Identify gestational diabetes mellitus by deep learning model from cell-free DNA at the early gestation stage","volume":"25","author":"Wang","year":"2023","journal-title":"Brief Bioinform"},{"issue":"1","key":"10.1016\/j.diabres.2026.113348_b0380","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12933-024-02381-1","article-title":"Predicting gestational diabetes mellitus risk at 11-13 weeks' gestation: the role of extrachromosomal circular DNA","volume":"23","author":"Wang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.diabres.2026.113348_b0385","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/pd.5671","article-title":"Association between cell-free DNA fetal fraction and gestational diabetes","volume":"40","author":"Hopkins","year":"2020","journal-title":"Prenat Diagn"},{"issue":"10","key":"10.1016\/j.diabres.2026.113348_b0390","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3109\/14767058.2013.766710","article-title":"Quantitative analysis of fetal DNA in maternal plasma in gestational diabetes mellitus, iron deficiency anemia and gestational hypertension pregnancies","volume":"26","author":"Zamanpoor","year":"2013","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:08:15Z","timestamp":1783458495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726002688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":78,"alternative-id":["S0168822726002688"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113348","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review on the latest progressions of cell-free DNA in diabetes and related microvascular or macrovascular complications","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113348"}}